Terrorist Attack - Continuity of Care (CUMP75)

September 8, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Attentats - Continuité Des Soins

On November 13th 2015, a terrorist attack killed 129 victims in Paris. An emergency crisis unit (CUMP) has been activated in Paris in the days following the attack and a subunit was in charge to answer to the phone calls of victims and their relatives. The same emergency crisis unit have been activated for the terrorist attack in London, 2017 june 3, terrorist attack in Barcelone 2017 august 17-18, terrorist attack in Strasbourg 2018 December 11 The purpose of this observational study is to document the evolution of psychiatric symptoms among subjects who called the CUMP and to collect information about the type of medical or non-medical care they were seeking for.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The care of the victims of natural disasters or mass disasters such as terrorist attacks is now better structured and organized. The efficacy of debriefing or of defusing has been and is still debated, sometimes bitterly. The aim of the present study is not to demonstrate utility or futility of such approaches, but to i) evaluate their global improvement over the past three years. ii) to list the type of support that the victims were seeking in their attempt to get rid of the symptoms which appeared after the terrorist attack of November 2015 in Paris.

iii) to collect their opinions about the way the CUMP (emergency medico-psychological unit of Paris, France) managed the support to the victims.

Participating subjects registered on the occasion of their first contact with the CUMP 75 by phone during the week following the attack

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • CUMP Paris

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Subjects who called the CUMP of Paris, London, Barcelone and Strasbourg after terrorist attacks were either direct, undirect victims or their relatives.

Description

Inclusion Criteria:

- All subjects who called the CUMP of Paris between November 13th, 2015 and January 31st, 2016; London 11th,2017 ; Barcelone 17-18th, 2017 ; Strasbourg 11th, 2018 and completed the questionnaire.

Exclusion Criteria:

- Subjects who did not consent to their participation to the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Subjects who contacted CUMP by phone
Subjects who contacted CUMP (Medical Psychological Emergency Cell) by phone from Paris November 13th, 2015, London 11th,2017 ; Barcelone 17-18th, 2017 ; Strasbourg 11th, 2018.
Overall Impression of the current state and evolution since the attacks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Global Impression - Improvement scale (CGI-I)
Time Frame: One day
Self-assessment of improvement or aggravation
One day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Global Impression - Severity scale (CGI-S)
Time Frame: One day
Self-assessment of symptom severity
One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gaëlle ABGRALL-BARBRY, MD, Assistance Publique - Hôpitaux de Paris
  • Study Chair: Gaëlle ABGRALL-BARBRY, MD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2020

Primary Completion (Actual)

October 22, 2020

Study Completion (Actual)

October 22, 2020

Study Registration Dates

First Submitted

December 6, 2018

First Submitted That Met QC Criteria

December 7, 2018

First Posted (Actual)

December 10, 2018

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 8, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder

Clinical Trials on Questionnaires

Subscribe